1-20 of 22
M T Lotze
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.

R M Berman, T Suzuki, H Tahara, P D Robbins, S K Narula, M T Lotze
Journal: The Journal of Immunology
J Immunol (1996) 157 (1): 231–238.
https://doi.org/10.4049/jimmunol.157.1.231
Published: 01 July 1996
View article titled, Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
Open the PDF for Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. in another window
Add to Citation Manager
Journal Articles

Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival.

L Qin, K D Chavin, Y Ding, H Tahara, J P Favaro, J E Woodward, T Suzuki, P D Robbins, M T Lotze, J S Bromberg
Journal: The Journal of Immunology
J Immunol (1996) 156 (6): 2316–2323.
https://doi.org/10.4049/jimmunol.156.6.2316
Published: 15 March 1996
View article titled, Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival.
Open the PDF for Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. in another window
Add to Citation Manager
Journal Articles

Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

L Zitvogel, H Tahara, P D Robbins, W J Storkus, M R Clarke, M A Nalesnik, M T Lotze
Journal: The Journal of Immunology
J Immunol (1995) 155 (3): 1393–1403.
https://doi.org/10.4049/jimmunol.155.3.1393
Published: 01 August 1995
View article titled, Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.
Open the PDF for Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. in another window
Add to Citation Manager
Journal Articles

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

H Tahara, L Zitvogel, W J Storkus, H J Zeh, 3rd, T G McKinney, R D Schreiber, U Gubler, P D Robbins, M T Lotze
Journal: The Journal of Immunology
J Immunol (1995) 154 (12): 6466–6474.
https://doi.org/10.4049/jimmunol.154.12.6466
Published: 15 June 1995
View article titled, Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
Open the PDF for Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. in another window
Add to Citation Manager
Journal Articles

Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.

T Itoh, W J Storkus, E Gorelik, M T Lotze
Journal: The Journal of Immunology
J Immunol (1994) 153 (3): 1202–1215.
https://doi.org/10.4049/jimmunol.153.3.1202
Published: 01 August 1994
View article titled, Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.
Open the PDF for Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes. in another window
Add to Citation Manager
Journal Articles

Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.

W J Storkus, H J Zeh, 3rd, M J Maeurer, R D Salter, M T Lotze
Journal: The Journal of Immunology
J Immunol (1993) 151 (7): 3719–3727.
https://doi.org/10.4049/jimmunol.151.7.3719
Published: 01 October 1993
View article titled, Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.
Open the PDF for Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. in another window
Add to Citation Manager
Journal Articles

Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes.

H L Wong, M T Lotze, L M Wahl, S M Wahl
Journal: The Journal of Immunology
J Immunol (1992) 148 (7): 2118–2125.
https://doi.org/10.4049/jimmunol.148.7.2118
Published: 01 April 1992
View article titled, Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes.
Open the PDF for Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. in another window
Add to Citation Manager
Journal Articles

IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4.

H Stötter, M C Custer, E S Bolton, L Guedez, M T Lotze
Journal: The Journal of Immunology
J Immunol (1991) 146 (1): 150–155.
https://doi.org/10.4049/jimmunol.146.1.150
Published: 01 January 1991
View article titled, IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4.
Open the PDF for IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. in another window
Add to Citation Manager
Journal Articles

IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.

D Jablons, E Bolton, S Mertins, M Rubin, P Pizzo, S A Rosenberg, M T Lotze
Journal: The Journal of Immunology
J Immunol (1990) 144 (9): 3630–3636.
https://doi.org/10.4049/jimmunol.144.9.3630
Published: 01 May 1990
View article titled, IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.
Open the PDF for IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis. in another window
Add to Citation Manager
Journal Articles

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.

J K McIntosh, D M Jablons, J J Mulé, R P Nordan, S Rudikoff, M T Lotze, S A Rosenberg
Journal: The Journal of Immunology
J Immunol (1989) 143 (1): 162–167.
https://doi.org/10.4049/jimmunol.143.1.162
Published: 01 July 1989
View article titled, In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.
Open the PDF for In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. in another window
Add to Citation Manager
Journal Articles

IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.

Y Kawakami, M C Custer, S A Rosenberg, M T Lotze
Journal: The Journal of Immunology
J Immunol (1989) 142 (10): 3452–3461.
https://doi.org/10.4049/jimmunol.142.10.3452
Published: 15 May 1989
View article titled, IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.
Open the PDF for IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. in another window
Add to Citation Manager
Journal Articles

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

D M Jablons, J J Mulé, J K McIntosh, P B Sehgal, L T May, C M Huang, S A Rosenberg, M T Lotze
Journal: The Journal of Immunology
J Immunol (1989) 142 (5): 1542–1547.
https://doi.org/10.4049/jimmunol.142.5.1542
Published: 01 March 1989
View article titled, IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.
Open the PDF for IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. in another window
Add to Citation Manager
Journal Articles

Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.

H Stötter, E A Wiebke, S Tomita, A Belldegrun, S Topalian, S A Rosenberg, M T Lotze
Journal: The Journal of Immunology
J Immunol (1989) 142 (5): 1767–1773.
https://doi.org/10.4049/jimmunol.142.5.1767
Published: 01 March 1989
View article titled, Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
Open the PDF for Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes. in another window
Add to Citation Manager
Journal Articles

Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.

R S Cotran, J S Pober, M A Gimbrone, Jr, T A Springer, E A Wiebke, A A Gaspari, S A Rosenberg, M T Lotze
Journal: The Journal of Immunology
J Immunol (1988) 140 (6): 1883–1888.
https://doi.org/10.4049/jimmunol.140.6.1883
Published: 15 March 1988
View article titled, Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.
Open the PDF for Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. in another window
Add to Citation Manager
Journal Articles

Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody.

P Perez, J A Titus, M T Lotze, F Cuttitta, D L Longo, E S Groves, H Rabin, P J Durda, D M Segal
Journal: The Journal of Immunology
J Immunol (1986) 137 (7): 2069–2072.
https://doi.org/10.4049/jimmunol.137.7.2069
Published: 01 October 1986
View article titled, Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody.
Open the PDF for Specific lysis of human tumor cells by T cells coated with anti-T3 cross-linked to anti-tumor antibody. in another window
Add to Citation Manager
Journal Articles

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

M T Lotze, Y L Matory, S E Ettinghausen, A A Rayner, S O Sharrow, C A Seipp, M C Custer, S A Rosenberg
Journal: The Journal of Immunology
J Immunol (1985) 135 (4): 2865–2875.
https://doi.org/10.4049/jimmunol.135.4.2865
Published: 01 October 1985
View article titled, In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
Open the PDF for In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. in another window
Add to Citation Manager
Journal Articles

In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

M T Lotze, L W Frana, S O Sharrow, R J Robb, S A Rosenberg
Journal: The Journal of Immunology
J Immunol (1985) 134 (1): 157–166.
https://doi.org/10.4049/jimmunol.134.1.157
Published: 01 January 1985
View article titled, In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.
Open the PDF for In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. in another window
Add to Citation Manager
Journal Articles

The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.

J H Donohue, M Rosenstein, A E Chang, M T Lotze, R J Robb, S A Rosenberg
Journal: The Journal of Immunology
J Immunol (1984) 132 (4): 2123–2128.
https://doi.org/10.4049/jimmunol.132.4.2123
Published: 01 April 1984
View article titled, The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.
Open the PDF for The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma. in another window
Add to Citation Manager
Journal Articles

Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.

J L Strausser, A Mazumder, E A Grimm, M T Lotze, S A Rosenberg
Journal: The Journal of Immunology
J Immunol (1981) 127 (1): 266–271.
https://doi.org/10.4049/jimmunol.127.1.266
Published: 01 July 1981
View article titled, Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
Open the PDF for Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. in another window
Add to Citation Manager
Journal Articles

In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity.

M T Lotze, S A Rosenberg
Journal: The Journal of Immunology
J Immunol (1981) 126 (6): 2215–2220.
https://doi.org/10.4049/jimmunol.126.6.2215
Published: 01 June 1981
View article titled, In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity.
Open the PDF for In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity. in another window
Add to Citation Manager